Methylome Variation Predicts Exemestane Resistance in Advanced ER+ Breast Cancer.
Liu XR, Zhang RY, Gong H, Rugo HS, Chen LB, Fu Y, Che JW, Tie J, Shao B, Wan FL, Kong WY, Song GH, Jiang HF, Xu GB, Li HP.
Liu XR, et al.
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033819896331. doi: 10.1177/1533033819896331.
Technol Cancer Res Treat. 2020.
PMID: 32129154
Free PMC article.